CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 1 - 10 of 830
Study Number Lead Group Study Title CIRB Study Status
S1400ANCILLARY SWOG Ancillary Study to Evaluate Patient and Physician Attitudes; Knowledge; and Expectations Related to Return of Genomic Results in Cancer in the SWOG 1400 (S1400) Clinical Trial Adult CIRB - Late Phase Emphasis
S1507 SWOG A Phase II Trial of Trametinib with Docetaxel in Patients with Kras Mutation Positive Non-Small Cell Lung Cancer (NSCLC) and Progressive Disease Following One or Two Prior Systemic Therapies Adult CIRB - Late Phase Emphasis Available to Open
10231 NCI NCORP Tissue Procurement Protocol: An NCI Cancer Moonshot Study Adult CIRB - Late Phase Emphasis Available to Open
NRG-GY003 NRG Phase II Randomized Trial of Nivolumab with or without Ipilimumab in Patients with Persistent or Recurrent Epithelial Ovarian; Primary Peritoneal or Fallopian Tube Cancer Adult CIRB - Early Phase Emphasis Available to Open
ANBL0531 COG Response- and Biology-Based Therapy for Intermediate-risk Neuroblastoma: A Groupwide Phase III Study Pediatric CIRB Available to Open
ABTC-1801 ABTC Phase I/II Study of BGB-290 with Temozolomide in Recurrent Gliomas with IDH1/2 Mutations Adult CIRB - Early Phase Emphasis Available to Open
NRG-GU005 NRG Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer Adult CIRB - Late Phase Emphasis Available to Open
EA1131 ECOG-ACRIN A Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy Vs. Capecitabine in Patients with Residual Triple-Negative Basal-Like Breast Cancer following Neoadjuvant Chemotherapy Adult CIRB - Late Phase Emphasis Available to Open
CALGB-80702 CALGB A Phase III Trial of 6 Versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer Adult CIRB - Late Phase Emphasis Available to Open
10317 ETCTN A Pilot Study of Nivolumab in Combination with Decitabine and Venetoclax in TP53-mutated Acute Myeloid Leukemia Adult CIRB - Early Phase Emphasis Available to Open
Displaying 1 - 10 of 830